Glamsmile Opens Shanghai Studio on February 21, 2011
24 February 2011 - 8:46AM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in research, development, and the manufacturing of oral and
cosmetic dentistry products, opened its largest four chair facility
in Shanghai yesterday.
"We are all excited about our biggest Studio opening in
potentially the best city in the world for veneers , Shanghai, on
Monday. Shanghai is one of the most galvanic cities in the world
today. Its cosmopolitan character, sophisticated and affluent
consumers and highly educated labor force, make it one of the most
exciting locations we have. With a population of approximately 19
million people plus the fact that many of the residents suffer with
tetracycline stains, makes Glamsmile the only operation of its
kind, a terrific fit for Shanghai," said Guy De Vreese, CEO of
Remedent.
"On opening day we seated two cases and we believe that there is
potential for our Shanghai Studio to follow or most likely exceed
the projected monthly cases of our other successful Studios in both
Hong Kong and Beijing in the near future, especially considering
that we anticipate our revenues in Beijing will increase by
approximately by 50% from the prior fiscal year," said Guy De
Vreese.
About Remedent
Remedent, Inc. specializes in the research, development,
manufacturing and the marketing of oral care and cosmetic dental
products. The company serves the professional dental industry with
breakthrough technology for dental veneers. These products are
supported by a line of professional veneer whitening and tooth
sensitivity solutions. Headquartered in Belgium, Remedent
distributes its products to more than 55 countries worldwide. For
more information, go to www.remedent.be, glamsmile.com and
glamsmile.cn.
Forward-Looking Statements
Statements in this press release that are "forward-looking
statements" are based on current expectations and assumptions that
are subject to risks and uncertainties. Such forward-looking
statements involve known and unknown risks, uncertainties and other
unknown factors that could cause Remedent's actual operating
results to be materially different from any historical results or
from any future results expressed or implied by such
forward-looking statements. In addition to statements that
explicitly describe these risks and uncertainties, readers are
urged to consider statements that contain terms such as "believes,"
"belief," "expects," "expect," "intends," "intend," "anticipate,"
"anticipates," "plans," "plan," "projects," "project," to be
uncertain and forward-looking. Actual results could differ
materially because of factors such as Remedent's ability to achieve
the value creation and results of operations as contemplated by its
business plans and objectives, and the risks related to expansion
and growth. For further information regarding risks and
uncertainties associated with Remedent's business, please refer to
the risk factors described in Remedent's filings with the
Securities and Exchange Commission, including, but not limited to,
its annual report on Form 10-K and quarterly reports on Form 10-Q.
We undertake no duty to revise or update any forward-looking
statements to reflect events or circumstances after the date of
this press release.
CONTACT: Stephen Ross 310 922 5685 docktor99@aol.com
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024